Obagi-C C-Rx System Normal-Dry Skin Intervention
NDC 62032-922, HYDROQUINONE, TITANIUM DIOXIDE, ZINC OXIDE, kit, from Obagi Cosmeceuticals LLC.
- Product NDC
- 62032-922
- Status
- Listed
- Labeler
- Obagi Cosmeceuticals LLC
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62032-922 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62032-922-01 | 62032092201 | 1 KIT in 1 BAG (62032-922-01) * 1 TUBE in 1 CARTON (62032-811-09) / 85 g in 1 TUBE * 177 mL in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC * 57 g in 1 BOTTLE, PLASTIC (62032-105-36) * 1 BOTTLE, GLASS in 1 CARTON (62032-106-10) / 30 mL in 1 BOTTLE, GLASS |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 62032-922 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62032-922 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62032-922. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.